The FDA's Celia Winchell, MD, told the panel that many of the symptoms patients reported were not easily captured in standard coding symptoms used in the attempts to analyze the data systematically. One especially common symptom, she said, was "feeling like a zombie" -- which "is not a diagnosis,"